The Shape of the Messenger: Using Protein Structure Information to Design Novel Cytokine-based Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|24|2113-2129

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.24, 2002-11, pp. : 2113-2129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor-Based Design of Cytokine Therapeutics

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 1, 2003-02 ,pp. : 1-20

Bentham Science Publishers

Access to resources Recommend Favorite

Computation-Based Design and Engineering of Protein and Antibody Therapeutics

By  

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 419-425

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Interactions Between the C-Terminus of A&bgr;-Peptide and Phospholipase A2 - A Structure Biology Based Approach to Identify Novel Alzheimer’s Therapeutics

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1224-1231

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Structure-Function Based Drug Design for Cancer Therapeutics)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 14, 2016-11 ,pp. : 1200-1200

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Structure Prediction in Structure Based Drug Design

By  

Current Medicinal Chemistry, Vol. 11, Iss. 5, 2004-03 ,pp. : 551-558

Bentham Science Publishers

Access to resources Recommend Favorite